kConFab Letter of Intent Submissions
DateInvestigatorsAffiliationProject Title
June 2009, due December 2009
Full project application
Margaret Cummings, Joanne Young, Mark Jenkins, Dan Buchanan, Michael Walsh, Sunil Lakhani QIMR, Royal Brisbane Hospital & The University of Melbourne Immunohistochemical analysis of mismatch repair (MMR) proteins in familial and
September 2009, due March 2010
pilot application
Stephen Fox & Gillian Mitchell Peter MacCallum Cancer Centre, Melbourne The identification of BRCA germline mutations using immunhistochemistry
September 2009, due March 2010
full application
Sunil Lakhani Royal Brisbane Hospital, Brisbane Expression of CT-X antigens in familial breast cancer
Nov 2009 Due May 2010
Full Application
Paul James, Gillian Mitchell, Alison Trainer, Judy Kirk, John Hopper; Melissa Southey, Stephen Fox, Ian Campbell Peter MacCallum Cancer Centre, University of Melbourne, Westmead Hopital Sydney Focus on pancreatic cancer
November 2009, due May 2010
Full application
Kelly Phillips, John Hopper, Michael Friedlander, Sue-Anne McLachlan, Roger Milne, David Goldgar PeterMacCallum Cancer centre, Prince of Wales Sydney, The University of Melbourne, Spanish National Cancer Centre, IBCCS, Utah Breast Cancer Risk in kConFab Women Known to be Negative for a Family Mutation in BRCA1 or BRCA2
December 2009, due June 2010
Full application
Melissa Southey & David Goldgar The University of Melbourne & The Utah University, USA Breast Cancer Susceptibility Gene Discovery through targeted and whole exome sequencing in High-risk BCFR families.
February 2010
Pilot application
Ashok Venkitaraman et al Hutchison/MRC Research Centre, University of Cambridge, UK Germline BRCA2 mutation carriers are at an increased risk of pancreatic ductal adenocarninoma.

A pilot or full application must be made within 6 months of submitting the letter of intent. If more than six months has elapsed, a new letter of intent must be submitted prior to the full application.